Nifurmazole

This classification denotes an anti-infective agent with the molecular formula C11H10N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) LOF2A7032C, chemically known as 3-(hydroxymethyl)-1-(3-(5-nitro-2-furyl)allylidenamino)-2,4-imidazolidindion but more generally known as nifurmazole, which bears US NIH Compound Identifier 72086. European Medicines Agency schedules Nifurmazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09268MIG. The term NIFURMAZOLE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 24, No. 11 1970, List 10). NIFURMAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule nifurmazole under HS 29349990 and SITC 51579. As of Q4 2014, NIFURMAZOLE remains US FDA's Preferred Term for this commodity. Nifurmazole bears US NLM identifiers UMLS ID C0068740 and NCI Concept Code C84016. SMILES: C1C(=O)N(C(=O)N1/N=C/C=CC2=CC=C(O2)[N+](=O)[O-])CO.